51³Ô¹ÏÍø

Tag - biogen

 
Menu
Search
 
July 25, 2026
 

Home Delivery
Subscribe for more access

BIOGEN

Eisai's Alzheimer's drug Lecanemab, also known as Leqembi
51³Ô¹ÏÍø / Science & Health
Mar 25, 2026
Research team confirms safety of Alzheimer¡¯s drug Lecanemab
The research team examined data on the health status of 2,672 patients 28 weeks after the start of the treatment.
Lecanemab was developed by drugmakers Eisai of Japan and Biogen of the United States.
51³Ô¹ÏÍø / Science & Health
Nov 15, 2024
European agency switches to recommending new Alzheimer¡¯s drug
The committee judged that the efficacy of lecanemab outweighs the risk for some patients.
A scientist looks at brain scans of a patient suffering from Alzheimer's disease in Geneva in 2023.
WORLD / Science & Health
Sep 21, 2024
Revolution or mirage? Controversy surrounds new Alzheimer¡¯s drugs
For defenders, the drugs represent a real chance to fight the disease. For detractors, they are a disappointment after a long line of costly failures.
Tests for patients suffering from Alzheimer's disease. According to the Alzheimer's Association, the disease is estimated to affect more than 6 million Americans.
WORLD / Science & Health / FOCUS
Apr 24, 2024
Alzheimer¡¯s drug adoption in U.S. slowed by doctors¡¯ skepticism
There is an entrenched belief among some doctors that treating the memory-robbing disease is futile.
Japan Times
WORLD / Science & Health
Jun 19, 2023
New Eisai and Biogen Alzheimer drug faces hurdles in Europe
Some doctors said its effect on the disease may not be clinically meaningful enough when weighed against the risk of brain swelling, its likely high price.
Japan Times
51³Ô¹ÏÍø
Jan 30, 2023
Priority review status given to Alzheimer¡¯s drug developed by Eisai and Biogen
The companies said priority review in Japan is granted to new medicines recognized as having high medical utility for serious diseases.
Japan Times
51³Ô¹ÏÍø / Science & Health
Dec 22, 2022
Japan approves blood test to detect Alzheimer¡¯s
Japan has approved one of the world¡¯s first blood test kits to detect signs of Alzheimer¡¯s disease, paving way for a simpler and speedier diagnosis of the ailment for which a therapy is on the horizon.
Japan Times
BUSINESS
Nov 30, 2022
Eisai Alzheimer¡¯s drug sparks debate over benefits as risks like brain bleeding emerge
The key issue is whether the modest slowing of the disease is meaningful to individual patients and their families, especially in light of the potential side effects.
BUSINESS / Markets
Nov 29, 2022
Eisai and Biogen plunge after report of second death in Alzheimer¡¯s trial
The case involved a 65-year-old woman who died of a massive brain hemorrhage after suffering a stroke and a type of brain swelling and bleeding in an Eisai trial, a report said.
Japan Times
COMMENTARY / World
Oct 4, 2022
New Alzheimer¡¯s drug from Biogen and Eisai is just the beginning
A successful late-stage trial of lecanemab gives researchers promising new avenues for tackling this hard-to-beat disease.
Japan Times
WORLD / Science & Health / ANALYSIS
Sep 30, 2022
Eisai drug¡¯s trial success raises hope for Alzheimer¡¯s prevention
Scientists have already begun to debate whether the benefit of the drug is robust enough, but to many researchers, the findings suggest that preventing decline altogether is possible.
Japan Times
51³Ô¹ÏÍø / Science & Health
Sep 28, 2022
Alzheimer¡¯s progression slowed by drug in major trial
The drug slowed cognitive decline in people with early Alzheimer¡¯s by 27% over 18 months when compared with a placebo using a common rating scale.
Japan Times
BUSINESS / Companies
Jul 6, 2022
Eisai says Alzheimer¡¯s drug will get priority review in U.S.
Under the accelerated approval pathway, drugs can be approved based on their ability to remove amyloid, a hallmark of the disease, from the brain.
Japan Times
BUSINESS
Apr 9, 2022
Japan¡¯s Eisai still seeking accelerated U.S. review of Alzheimer¡¯s drug
The firm said it plans to seek a quick approval even after the Medicare health plan decided to limit coverage of medicines approved in that manner.
Japan Times
WORLD / Science & Health
Jan 12, 2022
Biogen stung as U.S. limits coverage of Alzheimer¡¯s therapy
Private insurers in the U.S. have mostly declined to cover Aduhelm, saying they need more proof of its efficacy and that benefits outweigh risks like brain swelling.
Japan Times
WORLD
Sep 3, 2021
Lawmakers probe ¡®anomalies¡¯ in approval of Biogen Alzheimer¡¯s drug
The congressional inquiry adds to pressure on the U.S. agency charged with regulating products that account for one-fifth of consumer spending.
Japan Times
WORLD / Science & Health
Jul 29, 2021
Doctors blast Biogen Alzheimer approval as ¡®regulatory failure¡¯
The New England Journal of Medicine opinion piece is another sign of persistent furor over the agency¡¯s decision.
Japan Times
COMMENTARY / World
Jul 19, 2021
Latest U.S. Alzheimer¡¯s drug fix is a patch job
Most of the FDA¡¯s decisions don¡¯t receive national attention, which means they may not be rectified until substantial harm is done.
Japan Times
COMMENTARY / World
Jun 14, 2021
Alzheimer¡¯s drug furor highlights U.S. health system¡¯s failures
The FDA didn¡¯t deny that the clinical-trial evidence was poor. It simply ignored that problem and used different reasoning to grant the drug ¡®accelerated approval.¡±
Japan Times
WORLD / Science & Health / ANALYSIS
Jun 11, 2021
U.S. FDA faces mounting criticism over Alzheimer¡¯s drug approval
The drug was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer¡¯s, rather than proof that it slows progression of the disease.
Japan scientists identify clusters of protein believed to trigger Alzheimer¡¯s disease
A team of researchers said they found a ¡°seed¡± that accelerates the amyloid beta accumulation process in the brain, naming it ¡°Peak 1 amyloid beta,¡± as seen in a mouse's brain.
Indian brothers make manga debut in Japan
Two Indian brothers made their manga debut in Japan with "Kung Fu Kung Fool" ¡ª an action-comedy series that follows the adventures of a notorious thief and a young boy.
Japan weighs regulating Pokemon cards amid trading mania
A Pokemon event is held in Jakarta on July 11
Low-income families in Japan cut food and air conditioning during summer break
Yumiko Watanabe, the chairperson of nonprofit Kidsdoor, explains the results of a survey in Tokyo's Chiyoda Ward on July 1.
Iran strikes on CIA facilities prompt questions about possible Russian role
Iranian drones are displayed in an undisclosed location in Iran, in this handout image obtained on Jan. 13, 2025.U.S. officials have acknowledged that Russia has ?provided targeting ?and other support for Iran in its drone strikes on U.S. targets in the Persian Gulf region.
The sci-fi sensibilities of electronic trio Black Boboi
Black Boboi was formed in 2018 when solo artists Julia Shortreed, Utena Kobayashi and Ermhoi came together under Kobayashi¡¯s newly founded label, Bindividual.
A perfect storm: Kaze Fujii fans flock to Fuji Rock
Okayama-born singer-songwriter Kaze Fujii has carved out a distinctive place in Japanese pop since his major-label debut in 2019.
Can Japanese comedy get laughs in English? Yoshimoto Kogyo lets the jokes rip
Wes-P has millions of followers and his viral clips made him recognizable out of Japan.
The 180-day locals: Life on Japan¡¯s digital nomad visa
Christopher Flinn works remotely from Tokyo earlier this month. Japan issued 646 digital nomad visas in 2025, but tourism officials are hoping to increase that figure in the coming years, with Japan's relatively cheap cost of living and the weak yen seen as potential draws for young professionals.
Japan reveals hint of new defense spending target in fiscal blueprint
The Self-Defense Forces' Type 16 mobile combat vehicle fires during a joint live-fire drill with U.S. Marines as part of the annual Resolute Dragon exercises in Yufu, Oita Prefecture, on June 28.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo¡¯s Shinjuku Ward.
Kabukicho: Tokyo¡¯s ¡®stadium of desire¡¯

Longform

For many people, utility poles and power lines have become such a familiar part of Japan¡¯s landscape that they often go unnoticed.
Why Japan¡¯s utility poles won¡¯t be disappearing anytime soon
By Alex K.T. Martin

SUSTAINABLE 51³Ô¹ÏÍø

SPECIAL SUPPLEMENTS note

SUPPLEMENTS BINDER